This study presents a scalable EMR-based approach for reconstructing ABM dose and dose-volume metrics in EBRT patients. By capturing clinically relevant dose heterogeneity, we have estimated a more informative exposure variable than mean ABM dose for studies on the role of radiotherapy in leukemogenesis and other adverse health effects. Future work will improve the generalizability of these methods for certain treatment regions and pediatric populations.
Building similarity graph...
Analyzing shared references across papers
Loading...
Keith T Griffin
National Cancer Institute
Kishan Pithadia
National Cancer Institute
Hyemi Kim
Yonsei University
Washington University in St. Louis
Memorial Sloan Kettering Cancer Center
National Cancer Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Griffin et al. (Sun,) studied this question.
synapsesocial.com/papers/69a135b0ed1d949a99abfc67 — DOI: https://doi.org/10.1002/acm2.70494
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: